Psychotherapy and Psychosomatics

Regular Article

Factors Associated with Alexithymia in Patients Suffering from Depression

Honkalampi K. · Saarinen P. · Hintikka J. · Virtanen V. · Viinamäki H.

Author affiliations

Department of Psychiatry, Research and Development Unit, Kuopio University Hospital, Kuopio, Finland

Related Articles for ""

Psychother Psychosom 1999;68:270–275

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Regular Article

Published online: September 10, 1999
Issue release date: September – October

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS

Abstract

Background: We studied the factors associated with alexithymia in 137 depressed outpatients. Methods: Diagnosis of depression was confirmed by means of the Structured Clinical Interview for DSM-III-R. Alexithymia was screened using the 20-item version of the Toronto Alexithymia Scale. Severity of depression was assessed using the 21-item Beck Depression Inventory, and other psychiatric symptoms with the help of the Symptoms Checklist (SCL-90). Life satisfaction was also assessed with a structured scale. Results: Almost half of the patients were considered alexithymic. They were significantly more often male, unmarried and had a lower education than the nonalexithymic patients. Alexithymic patients more often showed psychiatric symptoms (SCL-90) and were also more often severely depressed and dissatisfied with their life than were the other patients. Logistic regression analyses revealed that four factors were independently associated with alexithymia: male gender, a low level of education, low life satisfaction and severe depression. Sleep disturbances were independently associated with alexithymia in men and severe depression in women. Conclusions: Alexithymia is very common among patients with depressive disorder. An awareness of these risk factors would be useful in improving the efficacy of treatment.




Related Articles:


References

  1. Sifneos PE: Short-Term Psychotherapy and Emotional Crises. Cambridge, Harvard University Press, 1972.
  2. Haviland MG, Reise SP: A California Q-set alexithymia prototype and its relationship to ego-control and ego-resiliency. J Psychosom Res 1996;41:597–608.
  3. Taylor GJ: The alexithymia construct: Conceptualization, validation, and relationships with basic dimensions of personality. New Trends Exp Clin Psychiatry 1994;10:61–74.
  4. Haviland MG, Shaw DG, MacMurray JP, Cummings MA: Validation of the Toronto Alexithymia Scale with substance abusers. Psychother Psychosom 1988;50:81–87.
  5. Wise TN, Jani NN, Kass E, Sonnenschein K, Mann LS: Alexithymia: Relationship to severity of medical illness and depression. Psychother Psychosom 1988; 50:68–71.
  6. Hendryx MS, Haviland MG, Shaw DG: Dimensions of alexithymia and their relationship to anxiety and depression. J Pers Assess 1991;56:227–237.
  7. Saarijärvi S, Salminen JK, Tamminen T, Äärelä E: Alexithymia in psychiatric consultation- liaison patients. Gen Hosp Psychiatry 1993;15:330–333.
  8. Rief W, Heuser J, Fichter MM: What does the Toronto Alexithymia Scale TAS-R measure? J Clin Psychol 1996;52:423–429.
  9. Äärelä E, Saarijärvi S, Salminen JK, Toikka T: Alexithymic features do not predict compliance with psychotherapy in consultation-liaison patients. Gen Hosp Psychiatry 1997;19:229–233.
  10. Parker DA, Bagby M, Taylor GJ: Alexithymia and depression: Distinct or overlapping construct? Compr Psychiatry 1991;32:387–394.
  11. Wise TN, Mann LS, Randell P: The stability of alexithymia in depressed patients. Psychopathology 1995;28:173–176.
  12. Wise TN, Mann LS, Hill B: Alexithymia and depressed mood in psychiatric patient. Psychother Psychosom 1990;54:26–31.
  13. Kauhanen J, Kaplan GA, Cohen RD, Julkunen J, Salonen JT: Alexithymia and risk of death in middle-aged men. J Psychosom Res 1996;41:541–549.
  14. Lumley MA, Ovies T, Stettner L, Wehmer F, Lakey B: Alexithymia, social support and health problems. J Psychosom Res 1996;41:519–530.
  15. Pasini A, Delle Chiaie R, Seripa S, Ciani N: Alexithymia as related to sex, age, and educational level: Results of Toronto Alexithymia Scale in 417 normal subjects. Compr Psychiatry 1992;33:42–46.
  16. Lumley MA, Mader C, Gramzow J, Papineau K: Family factors related to alexithymia characteristics. Psychosom Med 1996;58:211–216.
  17. Taylor GJ, Parker JDA, Bagby RM, Acklin MW: Alexithymia and somatic complaints in psychiatric out-patients. J Psychosom Res 1992;36:417–424.
  18. Kirmayer LJ, Robbins JM: Cognitive and social correlates of the Toronto Alexithymia Scale. Psychosomatics 1993;34:41–52.
  19. Feiguine RJ, Jones NF, Kassel PA: Distribution of alexithymic characteristics within an adult outpatient population. Psychother Psychosom 1988;50:61–67.
    External Resources
  20. Bach M, Bach D, Böhmer F, Nutzinger DO: Alexithymia and somatization: Relationship to DSM-III-R diagnoses. J Psychosom Res 1994;38:529–538.
  21. Joukamaa M, Lepola U: Alexithymic features in patients with panic disorder. Nord J Psychiatry 1994;48:33–36.
  22. Groot JM, Rodin G, Olmsted MP: Alexithymia, depression, and treatment outcome in bulimia nervosa. Compr Psychiatry 1995;36:53–60.
  23. Joukamaa M, Karlsson H, Sohlman B, Lehtinen V: Alexithymia and psychological distress among frequent attendance patients in health care. Psychother Psychosom 1996;65:199–202.
  24. Bach M, Bach D: Predictive value of alexithymia: A prospective study in somatizing patients. Psychother Psychosom 1995;64:43–48.
  25. Infrasca R: Alexithymia, neurovegetative arousal and neuroticism. Psychother Psychosom 1997;66:276–280.
  26. Spitzer RL, Williams JBW, Gibbon M, First MB: The structure of interview for DSM-III-R (SCID) I: History, rationale and description. Arch Gen Psychiatry 1992;49:624–629.
  27. Bagby RM, Parker JDA, Taylor GJ: The twenty-item Toronto Alexithymia Scale-I: Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:23–32.
  28. Lane RD, Sechrest L, Reidel R, Weldon V, Kaszniak A, Schwartz GE: Impaired verbal and non-verbal emotion recognition in alexithymia. Psychosom Med 1996;58:203–210.
  29. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100.
    External Resources
  30. Derogatis LR, Lipman RS, Covi L: SCL-90: An outpatient psychiatric rating scale – Preliminary report. Psychopharmacol Bull 1973;9:13–27.
  31. Allardt E: About dimension of welfare: An explanatory analysis of the comparative Scandinavian survey. University of Helsinki, Research Group of Comparative Sociology, Research Reports 1973, No. 1.
  32. Koivumaa-Honkanen H-T: Life Satisfaction as a Health Predictor. Med Sci. Kuopio, Kuopio University Publications D, 1998, number 143.
  33. Spitzer RL, Gibbon M, Williams JWB, Endicott J: Global assessment of functioning (GAF) scale; in Sederee LI, Dickey B (eds): Outcome Assessment in Clinical Practice. Baltimore, Williams & Wilkins, 1996.
  34. Holmes TH, Rahe RH: The Social Readjustment Rating Scale. J Psychosom Res 1967;11:213–218.
  35. Wechsler D: Wechsler Adult Intelligent Scale – Revised Manual. Cleveland, Psychological Corporation, 1981.
  36. Todarello O, Taylor GJ, Parker JDA, Fanelli M: Alexithymia in essential hypertensive and psychiatric outpatients: A comparative study. J Psychosom Res 1995;39: 987–994.
  37. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8–19.
  38. Fabrega H Jr, Mezzich J, Ulrich R, Benjamin L: Females and males in an intake psychiatric setting. Psychiatry 1990;53:1–16.
  39. Haviland MG, MacMurray JP, Cummings MA: The relationship between alexithymia and depressive symptoms in a sample of newly abstinent alcoholic inpatients. Psychother Psychosom 1988;49:37–40.
    External Resources
  40. Kauhanen J, Julkunen J, Salonen JT: Validity and reliability of Toronto Alexithymia Scale (TAS ) in a population study. J Psychosom Res 1992;36:687–694.
  41. Horley J: Life satisfaction, happiness and morale: Two problems with the use of subjective well-being indicators. Gerontologist 1984;24:124–127.
    External Resources
  42. Koivumaa-Honkanen H-T, Viinamäki H, Honkanen R, Tanskanen A, Antikainen R, Niskanen L, Jääskeläinen J, Lehtonen J: Correlates of life satisfaction among psychiatric patients. Acta Psychiatr Scand 1996;94:372–378.
  43. Shapiro CM: Alexithymia – A useful concept for all psychiatrists? J Psychosom Res 1996;41:503–504.

Article / Publication Details

First-Page Preview
Abstract of Regular Article

Published online: September 10, 1999
Issue release date: September – October

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP